Oxbridge Re Holdings Limited (OXBR) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 623K | 576K | 645K | 664K | 692K | 422K | 205K | 44K | -125K | -1.91M | -6.38M | 691K |
| Revenue Growth % | -9.97% | 36.49% | 214.63% | 1409.09% | 653.6% | 122.15% | 103.21% | -93.63% | -122.89% | -283% | -816.81% | 37.38% |
| Medical Costs & Claims | 0 | 510K | 61K | 2.36M | 0 | 66K | 66K | 62K | 60K | 61K | 60K | 20K |
| Medical Cost Ratio % | 0% | 88.54% | 9.46% | 354.97% | 0% | 15.64% | 32.2% | 140.91% | -48% | -3.2% | -0.94% | 2.89% |
| Gross Profit | 623K | 66K | 584K | -1.69M | 692K | 356K | 139K | -18K | -185K | -1.97M | -6.44M | 671K |
| Gross Margin % | 100% | 11.46% | 90.54% | -254.97% | 100% | 84.36% | 67.8% | -40.91% | 148% | 103.2% | 100.94% | 97.11% |
| Gross Profit Growth % | -9.97% | -81.46% | 320.14% | -9305.56% | 474.05% | 118.11% | 102.16% | -102.68% | -133.88% | -288.86% | -251.2% | 39.21% |
| Operating Expenses | 583K | 531K | 754K | 1.26M | 570K | 431K | 432K | 566K | 488K | 475K | 628K | 677K |
| OpEx / Revenue % | 93.58% | 92.19% | 116.9% | 189.31% | 82.37% | 102.13% | 210.73% | 1286.36% | -390.4% | -24.93% | -9.84% | 97.97% |
| Depreciation & Amortization | 1K | 1K | 0 | 0 | 0 | 0 | 1K | 0 | 2K | 1K | 2K | 1K |
| Combined Ratio % | 93.58% | 180.73% | 126.36% | 544.28% | 82.37% | 117.77% | 242.93% | 1427.27% | -438.4% | -28.14% | -10.78% | 100.87% |
| Operating Income | 40K | -465K | -170K | -2.95M | 122K | -75K | -293K | -584K | -673K | -2.44M | -7.07M | -6K |
| Operating Margin % | 6.42% | -80.73% | -26.36% | -444.28% | 17.63% | -17.77% | -142.93% | -1327.27% | 538.4% | 128.14% | 110.78% | -0.87% |
| Operating Income Growth % | -67.21% | -520% | 41.98% | -405.14% | 118.13% | 96.93% | 95.86% | -9633.33% | -573.94% | -460.03% | -227.72% | -106.45% |
| EBITDA | 41K | -464K | -170K | -2.95M | 122K | -75K | -292K | -584K | -671K | -2.44M | -7.07M | -5K |
| EBITDA Margin % | 6.58% | -80.56% | -26.36% | -444.28% | 17.63% | -17.77% | -142.44% | -1327.27% | 536.8% | 128.08% | 110.75% | -0.72% |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 40K | -465K | -170K | -2.95M | 122K | -75K | -293K | -584K | -673K | -2.44M | -7.07M | -6K |
| Pretax Margin % | 6.42% | -80.73% | -26.36% | -444.28% | 17.63% | -17.77% | -142.93% | -1327.27% | 538.4% | 128.14% | 110.78% | -0.87% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 24K | -569K | -185K | -2.82M | 108K | -214K | -293K | -584K | -673K | -2.44M | -7.07M | -6K |
| Net Margin % | 3.85% | -98.78% | -28.68% | -424.55% | 15.61% | -50.71% | -142.93% | -1327.27% | 538.4% | 128.14% | 110.78% | -0.87% |
| Net Income Growth % | -77.78% | -165.89% | 36.86% | -382.71% | 116.05% | 91.23% | 95.86% | -9633.33% | -573.94% | -460.03% | -227.72% | -106.45% |
| EPS (Diluted) | 0.00 | 0.02 | -0.02 | -0.25 | -0.02 | -0.08 | -0.09 | -0.14 | -0.15 | -0.46 | -1.20 | -0.00 |
| EPS Growth % | 113.93% | 120.88% | 72.34% | -78.57% | 86.6% | 83.65% | 92.65% | - | -719.83% | -355.56% | -221.65% | -106.21% |
| EPS (Basic) | 0.00 | 0.02 | -0.02 | -0.25 | -0.02 | -0.08 | -0.09 | -0.14 | -0.15 | -0.46 | -1.20 | -0.00 |
| Diluted Shares Outstanding | 7.8M | 7.39M | 7.66M | 7.44M | 6.9M | 6.12M | 6.12M | 6.01M | 6.01M | 5.87M | 5.87M | 5.87M |